Aadi Bioscience, Inc. (AADI)
NASDAQ
Market Cap
$73.55M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
503 of 950
Rank in Industry
271 of 543
Largest Insider Buys in Sector
AADI Stock Price History Chart
AADI Stock Performance
About Aadi Bioscience, Inc.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Insider Activity of Aadi Bioscience, Inc.
Over the last 12 months, insiders at Aadi Bioscience, Inc. have bought $0 and sold $598,903 worth of Aadi Bioscience, Inc. stock.
On average, over the past 5 years, insiders at Aadi Bioscience, Inc. have bought $23.4M and sold $767,930 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,529,402 shares for transaction amount of $20M was made by Dalal Anupam (director) on 2021‑08‑26.
List of Insider Buy and Sell Transactions, Aadi Bioscience, Inc.
| 2024-10-03 | Sale | CHIEF EXECUTIVE OFFICER | 9,689 0.04% | $1.94 | $18,797 | +20.05% | ||
| 2024-09-03 | Sale | EXECUTIVE CHAIRMAN | 40,000 0.1595% | $1.71 | $68,316 | +23.28% | ||
| 2024-08-05 | Sale | EXECUTIVE CHAIRMAN | 5,652 0.0224% | $1.34 | $7,595 | +52.17% | ||
| 2024-08-02 | Sale | EXECUTIVE CHAIRMAN | 18,933 0.0777% | $1.41 | $26,705 | +50.00% | ||
| 2024-08-01 | Sale | EXECUTIVE CHAIRMAN | 15,415 0.0618% | $1.50 | $23,055 | +36.84% | ||
| 2024-07-02 | Sale | EXECUTIVE CHAIRMAN | 8,652 0.0296% | $1.34 | $11,612 | 0.00% | ||
| 2024-07-01 | Sale | EXECUTIVE CHAIRMAN | 31,348 0.1161% | $1.45 | $45,605 | 0.00% | ||
| 2024-06-04 | Sale | EXECUTIVE CHAIRMAN | 20,225 0.0827% | $1.77 | $35,746 | +10.51% | ||
| 2024-06-03 | Sale | EXECUTIVE CHAIRMAN | 19,775 0.0805% | $1.81 | $35,765 | +7.18% | ||
| 2024-05-01 | Sale | EXECUTIVE CHAIRMAN | 40,000 0.162% | $1.93 | $77,184 | -1.55% | ||
| 2024-04-02 | Sale | EXECUTIVE CHAIRMAN | 22,228 0.0925% | $2.23 | $49,513 | -12.39% | ||
| 2024-04-01 | Sale | EXECUTIVE CHAIRMAN | 17,772 0.0725% | $2.31 | $41,101 | -17.32% | ||
| 2024-03-04 | Sale | EXECUTIVE CHAIRMAN | 14,964 0.0532% | $2.10 | $31,415 | -20.82% | ||
| 2024-03-01 | Sale | EXECUTIVE CHAIRMAN | 27,036 0.113% | $1.97 | $53,226 | +0.52% | ||
| 2024-02-01 | Sale | Executive Chairman | 42,000 0.1683% | $1.74 | $73,269 | +9.66% | ||
| 2024-01-02 | Sale | Executive Chairman | 42,000 0.1709% | $2.06 | $86,549 | -7.77% | ||
| 2023-12-06 | Sale | Executive Chairman | 7,037 0.0294% | $4.82 | $33,914 | -59.57% | ||
| 2023-12-05 | Sale | Executive Chairman | 15,740 0.0662% | $5.02 | $78,941 | -61.07% | ||
| 2023-12-04 | Sale | Executive Chairman | 10,876 0.0447% | $5.15 | $55,986 | -62.82% | ||
| 2023-12-01 | Sale | Executive Chairman | 8,347 0.035% | $5.14 | $42,881 | -61.92% |
Insider Historical Profitability
<0.0001%
| Desai Neil | EXECUTIVE CHAIRMAN | 1171543 4.7468% | $2.98 | 0 | 44 | |
| Lennon David James | CHIEF EXECUTIVE OFFICER | 22869 0.0927% | $2.98 | 0 | 1 | |
| Satter Muneer A | 5621835 22.7783% | $2.98 | 33 | 0 | ||
| Khuong Chau Quang | 5193946 21.0446% | $2.98 | 2 | 0 | ||
| Novartis Bioventures Ltd | 10 percent owner | 4049804 16.4088% | $2.98 | 1 | 21 | |
| WEISS PAUL M | director | 1576167 6.3862% | $2.98 | 1 | 0 | |
| Dalal Anupam | director | 1529402 6.1968% | $2.98 | 1 | 0 | <0.0001% |
| Gardner Joseph H. | President | 453019 1.8355% | $2.98 | 3 | 0 | <0.0001% |
| PETERS KEVIN G. | Chief Scientific Officer | 320536 1.2987% | $2.98 | 1 | 0 | |
| Castelein Caley | director | 259998 1.0534% | $2.98 | 2 | 0 | <0.0001% |
| HOFFMAN STEPHEN J | Chief Executive Officer | 31967 0.1295% | $2.98 | 2 | 0 | |
| ORBIMED ADVISORS LLC | 10 percent owner | 0 0% | $2.98 | 2 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Avoro Capital Advisors Llc | $6.67M | 11.61 | 2.85M | 0% | +$0 | 0.08 | |
| ACUTA CAPITAL PARTNERS LLC | $4.33M | 7.53 | 1.85M | 0% | +$0 | 2.81 | |
| Alerce Investment Management L P | $3.82M | 6.64 | 1.63M | 0% | +$0 | 0.05 | |
| BlackRock | $2.44M | 4.24 | 1.04M | -3.76% | -$95,062.42 | <0.0001 | |
| The Vanguard Group | $2M | 3.49 | 856,836 | -0.33% | -$6,694.74 | <0.0001 | |
| Renaissance Technologies | $1.27M | 2.21 | 543,722 | +36.37% | +$339,217.47 | <0.01 | |
| Citadel Advisors LLC | $1.21M | 2.11 | 517,576 | +26.94% | +$257,058.18 | <0.01 | |
| Vivo Capital | $1.19M | 2.08 | 509,572 | 0% | +$0 | 0.1 | |
| Morgan Stanley | $1.09M | 1.89 | 464,466 | -9.05% | -$108,119.85 | <0.0001 | |
| Geode Capital Management | $934,327.00 | 1.63 | 399,231 | +0.85% | +$7,896.23 | <0.0001 | |
| State Street | $877,844.00 | 1.53 | 375,147 | +19.13% | +$140,956.92 | <0.0001 | |
| Acuitas Investments, LLC | $744,445.00 | 1.3 | 318,139 | New | +$744,445.00 | 0.4 | |
| 683 Capital Management Llc | $468,000.00 | 0.82 | 200,000 | 0% | +$0 | 0.05 | |
| Parallel Advisors, LLC | $377,199.00 | 0.66 | 161,196 | +2,415.54% | +$362,204.27 | 0.01 | |
| Northern Trust | $371,602.00 | 0.65 | 158,804 | -2.19% | -$8,328.07 | <0.0001 | |
| Ohio Strs | $363,000.00 | 0.63 | 155,500 | +2,256.06% | +$347,592.93 | <0.01 | |
| Tealwood Asset Management | $135,269.00 | 0.24 | 57,807 | New | +$135,269.00 | 0.03 | |
| Goldman Sachs | $116,015.00 | 0.2 | 49,579 | New | +$116,015.00 | <0.0001 | |
| BNY Mellon | $102,628.00 | 0.18 | 43,858 | -12.32% | -$14,414.44 | <0.0001 | |
| Schonfeld Group | $97,578.00 | 0.17 | 41,700 | 0% | +$0 | <0.01 | |
| D. E. Shaw & Co. | $96,146.00 | 0.17 | 41,088 | +72.04% | +$40,259.73 | <0.0001 | |
| Susquehanna International Group | $90,593.00 | 0.16 | 38,715 | +23.13% | +$17,018.80 | <0.0001 | |
| Charles Schwab | $86,756.00 | 0.15 | 37,075 | -18.28% | -$19,408.07 | <0.0001 | |
| Prelude Capital | $85,637.00 | 0.15 | 36,597 | +38.64% | +$23,868.01 | 0.01 | |
| Dimensional Fund Advisors | $83,292.00 | 0.15 | 35,595 | 0% | +$0 | <0.0001 | |
| Verition Fund Management Llc | $75,336.00 | 0.13 | 32,195 | New | +$75,336.00 | <0.01 | |
| Abg Innovation Capital Partners Iii Gp Ltd | $62,398.00 | 0.11 | 26,666 | 0% | +$0 | 7.5 | |
| Xtx Topco Ltd | $62,010.00 | 0.11 | 26,500 | +159.07% | +$38,074.14 | <0.01 | |
| RhumbLine Advisers | $59,396.00 | 0.1 | 25,386 | +2.38% | +$1,378.09 | <0.0001 | |
| Prudential Financial | $49,971.00 | 0.09 | 21,355 | New | +$49,971.00 | <0.0001 | |
| Nuveen | $48,936.00 | 0.09 | 20,913 | 0% | +$0 | <0.0001 | |
| UBS | $48,464.00 | 0.08 | 20,711 | +16.62% | +$6,905.38 | <0.0001 | |
| Barclays | $27,000.00 | 0.05 | 11,356 | -48.99% | -$25,927.70 | <0.0001 | |
| T. Rowe Price | $26,000.00 | 0.04 | 10,692 | 0% | +$0 | <0.0001 | |
| New York State Common Retirement Fund | $25,000.00 | 0.04 | 10,731 | +5.81% | +$1,372.19 | <0.0001 | |
| Bank of America | $24,182.00 | 0.04 | 10,334 | -67.25% | -$49,644.00 | <0.0001 | |
| Wells Fargo | $22,910.00 | 0.04 | 9,791 | +8.14% | +$1,724.51 | <0.0001 | |
| American International Group | $18,704.00 | 0.03 | 7,993 | -0.86% | -$161.46 | <0.0001 | |
| JPMorgan Chase | $16,366.00 | 0.03 | 6,994 | -33.69% | -$8,316.38 | <0.0001 | |
| Fidelity Investments | $9,381.00 | 0.02 | 4,009 | +57.71% | +$3,432.76 | <0.0001 | |
| Federated Hermes | $8,691.00 | 0.02 | 3,714 | +716.26% | +$7,626.27 | <0.0001 | |
| Citigroup | $8,417.00 | 0.02 | 3,597 | +54.91% | +$2,983.51 | <0.0001 | |
| U.S. Bancorp | $7,799.00 | 0.01 | 3,333 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $8,187.00 | 0.01 | 3,499 | -33.62% | -$4,146.15 | <0.0001 | |
| CalSTRS | $4,310.00 | 0.01 | 1,842 | -31.01% | -$1,937.39 | <0.0001 | |
| Simplex Trading Llc | $3,000.00 | 0.01 | 1,451 | -68.87% | -$6,636.80 | <0.0001 | |
| Legal & General | $3,473.00 | 0.01 | 1,484 | 0% | +$0 | <0.0001 | |
| Ameritas Investment Partners Inc | $2,541.00 | <0.01 | 1,086 | 0% | +$0 | <0.0001 | |
| Public Employees Retirement System Of Ohio | $2,340.00 | <0.01 | 1,000 | -87.18% | -$15,912.00 | <0.0001 | |
| Russell Investments Group Ltd | $2,270.00 | <0.01 | 970 | New | +$2,270.00 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.